Tests:Thrombin Clotting Time, Plasma: Difference between revisions
- Department
- Haematology
Tests:Thrombin Clotting Time, Plasma
Created page with "{{DISPLAYTITLE: Thrombin Clotting Time, Plasma}} Full Test List Haematology Tests {| class="wikitable" ! colspan="2" | == Overview == |- |Department |Haematology |- |Test Code | |- |Synonyms |TCT Thrombin Time |- |Turnaround Time |1-4 hrs |- |Stability – Add test |24 hrs |- ! colspan="2" | == Specimen Requirements == |- |Specimen Type |Plasma |- |Specimen Transportation | |- |Preferred |Full 2.7 mL Na citrate <span style="background: #87c..." |
No edit summary |
||
| Line 40: | Line 40: | ||
| | | | ||
|- | |- | ||
| | |Unacceptable | ||
| | |||
|- | |||
|Paediatric Requirements | |||
|1 mL Na Citrate <span style="background: #87cefa "> Blue-Top </span> | |1 mL Na Citrate <span style="background: #87cefa "> Blue-Top </span> | ||
|- | |- | ||
Revision as of 17:00, 25 February 2025
Overview | |
|---|---|
| Department | Haematology |
| Test Code | |
| Synonyms | TCT
Thrombin Time |
| Turnaround Time | 1-4 hrs |
| Stability – Add test | 24 hrs |
Specimen Requirements | |
| Specimen Type | Plasma |
| Specimen Transportation | |
| Preferred | Full 2.7 mL Na citrate Blue-Top |
| Acceptable | |
| Unacceptable | |
| Paediatric Requirements | 1 mL Na Citrate Blue-Top |
Aliquot Requirements | |
| Sample Type | |
| Minimum Volume | |
| Aliquot Transportation | |
Clinical Information | |
| Reference Intervals | Reference Range: < 21 sec.
Interpretation of TCT and Protamine TCT: TCT TCT + PrSo4 Interpretation Prolonged Normal Consistent with Heparin Prolonged Prolonged Consistent with Dabigatran, DIC, low fibrinogen. |
| Test Method | Mechanical clot detection performed on Stago Compact Max2 Analyser |
| Advanced Notice | Not required |
| Patient Preparation | Not required |
Comments | |
| Thrombin clotting time is performed with a coagulation screen
Protamine sulphate may be added to the TCT to exclude or indicate heparin contamination. Any prolongation of the thrombin time may indicate the presence of a high level fibrin degradation products, hypo- or afibrinogenemia, dysfibrinogenemia, the presence of Heparin, Dabigatran, or a high concentration of serum proteins. | |